At 13.5x earnings and just 11.1x forward earnings, CENTA trades like a no-growth defensive despite generating a 7.10% ROIC and holding a solid Piotroski F-Score of 7. The market is pricing in muted expansion, reflected in a PEG of 2, yet the balance sheet risk appears manageable with an Altman Z-Score of 2.5 and a strong 3.4 current ratio. A 1.3x price-to-book and 0.7x price-to-sales multiple suggest limited optimism embedded in the stock. This is not a distressed asset, but it is priced like a low-expectation compounder—arguably a mispricing if operational consistency continues and forward earnings of $2.47 materialize.
⚠️ Financial Disclaimer:
This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate. We may earn a commission from partner links.